From July 1, 2024 to July 8, 2024, the company has repurchased 1,786,500 shares, representing 0.09% for CNY 3.71 million. With this, the company has completed the repurchase of 47,445,540 shares, representing 2.47% for CNY 199.91 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 CNY | -0.89% |
|
+0.60% | -24.55% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.55% | 89Cr | |
+13.97% | 494.71Cr | |
-32.08% | 359.99Cr | |
-1.63% | 302.53Cr | |
-24.62% | 265.85Cr | |
-9.82% | 234.38Cr | |
+38.87% | 185.45Cr | |
+38.84% | 145.23Cr | |
-15.47% | 141Cr | |
+40.95% | 138.48Cr |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.